Asymptomatic Inflammatory Bowel Disease Presenting With Mucocutaneous Findings
http://www.100md.com
《小儿科》
Department of Dermatology and Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin
Department of Gastroenterology and Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin
Department of Dermatology and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
ABSTRACT
Although inflammatory bowel disease (IBD) typically presents with gastrointestinal complaints, mucocutaneous lesions are commonly associated and can precede gastrointestinal symptoms, thereby alerting the clinician to the diagnosis of IBD before the onset of gastrointestinal symptoms. Nine children are reported who had no gastrointestinal symptoms suggestive of IBD but presented with mucocutaneous findings of IBD and were subsequently diagnosed with Crohn's disease or ulcerative colitis based on characteristic features on gastrointestinal endoscopy and/or biopsies. The majority of the patients had oral and perianal lesions. We believe that IBD is a common etiology for persistent oral lesions in the pediatric population. In addition to a good history, children with unexplained oral mucous membrane lesions should have an examination of the rectal and genital mucosa as well as tests for complete blood count, iron levels, sedimentation rate, albumin, and occult blood in the stool with endoscopy and biopsies to rule out IBD if indicated.
Key Words: Crohn's disease cutaneous inflammatory bowel disease oral pediatrics
Abbreviations: IBD, inflammatory bowel disease 6-MP, 6-mercaptopurine ESR, erythrocyte sedimentation rate
Inflammatory bowel disease (IBD) is a group of gastrointestinal disorders characterized by relapsing and remitting signs and symptoms. Intestinal manifestations such as abdominal pain, diarrhea, fever, weight loss, and extraintestinal manifestations including mucocutaneous lesions, iritis, and arthritis may be associated with IBD. Mucocutaneous lesions are relatively common during the course of IBD. Less commonly, however, they can be a presenting finding, thereby alerting the clinician to the diagnosis of IBD before the onset of gastrointestinal symptoms. We describe 9 children from 2 medical institutions in whom mucocutaneous lesions preceded abdominal manifestations and led to an early diagnosis of IBD.
REPRESENTATIVE CASES
Patient 1
A 6-year-old white boy presented with a 5-month history of intermittent upper-lip swelling associated with eczematous skin changes and gingival edema (Fig 1). Over the subsequent 3 years, he developed worsening of the upper-lip swelling as well as angular cheilitis and lower-lip involvement (Fig 2). He denied any systemic symptoms including facial paralysis, abdominal pain, and diarrhea. A biopsy specimen from the oral mucosa showed a hyperplastic mucosa with spongiosis and a dense lymphocytic infiltrate with small granulomas in the submucosa. Patch tests, complete blood count, tuberculosis skin tests, chest radiograph, and pulmonary function tests were within normal limits.
A repeat biopsy was planned because of lack of improvement with several therapies including topical steroids, antihistamines, amoxicillin-clavulanate, and minocycline for presumed Melkersson-Rosenthal syndrome. On returning to the clinic for biopsy, his mother mentioned a perianal pustule that had been present for some time. Given this new information, the oral biopsy was not performed; he instead was referred to a gastroenterologist. The patient was found to have microcytic anemia (hemoglobin: 11.1 g/dL; mean corpuscular volume: 75 fL) and hypoalbuminemia (3.3 g/dL) at that time. Esophagogastroduodenoscopy was unremarkable; however, patchy erythema, erosions, and pseudopolyps were seen during colonoscopy. Biopsies from the colon showed gastritis, terminal ileum granulomas, and granulomatous colitis, confirming the diagnosis of Crohn's disease.
The perianal lesion proved to be a fistula, and 6-mercaptopurine (6-MP) was started. Metronidazole was added intermittently to treat the fistula further. There was mild improvement of the granulomatous cheilitis; however, the fistula remained patent. Infliximab was started, with complete resolution of the oral lesions, closure of the fistula, and normalization of laboratory abnormalities after 3 infusions. He is in clinical and biochemical remission without intestinal or extraintestinal manifestations while maintained on scheduled 8- to 10-week-interval infliximab therapy.
Patient 2
An 8-year-old white boy had a 2-year history of recurrent oral ulcerations with hyperplastic ridges in the inferior gingival sulcus bilaterally (Fig 3). He denied any gastrointestinal symptoms. A previous oral biopsy was reviewed and showed a small granuloma in the submucosa. He also had a history of perianal skin tags and fissures. Gastrointestinal evaluation revealed esophagitis, gastritis, and multiple aphthous ulcers in the sigmoid colon. Biopsy specimens showed esophagitis with granulomas and granulomatous colitis consistent with Crohn's disease. Work-up subsequently revealed hypoalbuminemia (3.2 g/dL) and an elevated erythrocyte sedimentation rate (ESR) (32 mm/hour). Monotherapy with 6-MP resulted in resolution of his oral ulcers.
Patient 3
A 12-year-old obese white boy (body mass index: 97th percentile) presented with a 6-month history of an erythematous plaque on his right lower extremity that more recently had become warm to the touch, tender, and ulcerated with indurated violaceous borders (Fig 4). The patient denied any trauma to the area. Two biopsies performed elsewhere were consistent with folliculitis, and the patient had been treated with Augmentin and topical antibiotics with no improvement. Repeat biopsy showed suppurative folliculitis which, along with the typical clinical presentation, was consistent with pyoderma gangrenosum. Fungal culture and acid-fast bacillus stains were negative. His ESR was slightly elevated (14 mm/hour). The patient denied any gastrointestinal complaints, but upper and lower endoscopy showed multiple ulcerations in the gastric antrum and ileum. Biopsy specimens showed gastritis, ileitis, and crypt destruction with giant-cell reaction in the colon consistent with Crohn's disease. He initially received intralesional corticosteroids for the pyoderma gangrenosum; however, after the diagnosis of Crohn's disease was made, infliximab and methotrexate were initiated, which led to almost complete resolution of the pyoderma gangrenosum.
RESULTS
In our series of children with silent IBD, mucocutaneous lesions appeared before gastrointestinal signs as the manifestation of Crohn's disease (8 of 9) or ulcerative colitis (1 of 9). (Table 1 provides a summary of these cases.) Of the 9 patients, 8 were male, and the mean age was 8 years. Although patients with IBD tend not to be overweight, 2 of our patients were obese (patients 3 and 8). Six children presented with oral manifestations, 1 had genital lesions, and 2 had pyoderma gangrenosum. All patients were asked about gastrointestinal symptoms, fever, weight loss, and joint pain at presentation and denied any such symptoms. The majority of our patients (7 of 9) had perianal lesions at presentation; however, several of the perianal lesions were not discovered on initial evaluation but only became apparent during subsequent examinations. The time to diagnosis of IBD after development of the mucocutaneous findings ranged from 1 month to 42 months. In general, patients with oral and perianal lesions experienced a longer time until diagnosis compared with patients with lesions that presented elsewhere. One patient (patient 8) was diagnosed with Crohn's disease on repeat endoscopy after the initial endoscopy that was performed 1.5 years prior was normal. In all patients followed after instituting therapy, the mucocutaneous lesions responded to therapy for their IBD.
DISCUSSION
Although IBD typically presents with gastrointestinal complaints, mucocutaneous lesions have been reported to occur in 15% to 44% of cases and, when present, can precede gastrointestinal symptoms.1,2,3,4 Gregory and Ho5 reviewed the mucocutaneous lesions of IBD and divided them into specific, reactive, and miscellaneous categories (Table 2).
Although uncommon in children, pyoderma gangrenosum is a common mucocutaneous feature of IBD. Typically, the early papulopustules or hemorrhagic bullae rapidly enlarge, become necrotic, and ulcerate. The ulcerations have a characteristic violaceous, undermined border (Fig 4). Lesions can occur on any part of the body but are most frequently located on the lower extremities. Pyoderma gangrenosum is characterized by pathergy (predilection for lesions in areas of trauma); thus, aggressive debridement must be avoided. Twenty percent of adult patients with pyoderma gangrenosum will have associated IBD.6 It is associated more commonly with ulcerative colitis than Crohn's disease, occurring in 5% to 12% and 1% to 2% of patients, respectively.3,5,7 Pyoderma gangrenosum is uncommon in children, with 4% of cases reported in children <15 years old.8 Although IBD is the most common underlying cause of pyoderma gangrenosum in children, pyoderma gangrenosum in children can be associated with several other systemic disorders including immunodeficiencies (primary and HIV related), leukemia, hepatitis, and arthritis.9,10 The occurrence of pyoderma gangrenosum preceding gastrointestinal symptoms in IBD has only been described in a few patients.6,8,11
Perianal lesions including skin tags, fistulas, fissures, and abscesses are characteristic of Crohn's disease and occur during the course of IBD in 60% to 82% of patients; however, 25% to 30% of patients show perianal lesions before gastrointestinal complaints.12,13 The majority of our patients with Crohn's disease (6 of 8), as well as our 1 patient with ulcerative colitis, were noted to have perianal lesions before gastrointestinal symptoms. It is interesting to note that the 2 patients with Crohn's disease who did not have perianal lesions had pyoderma gangrenosum as their initial finding. Of the patients with perianal lesions, in only 2 (patients 8 and 9) was the perianal lesion the presenting complaint. This suggests that perianal lesions may often be present before gastrointestinal complaints but are less often brought to the attention of the physician, especially in adolescent boys.
Although not as well documented, oral lesions associated with IBD are relatively common, occurring in 6% to 20% of patients.14 When present, they are the presenting sign/symptom in approximately one half of cases.1,4,15–1617 In addition, more recent reviews have found an increased prevalence of various oral lesions in IBD, particularly in children. Barnard and Walker-Smith found that 80% of pediatric patients with Crohn's disease and 41% of children with ulcerative colitis had oral lesions in their series of patients.18 In reviews by Pittock et al19 and Plauth et al,4 48% and 66% of patients with Crohn's disease, respectively, were found to have oral manifestations, with an increased prevalence in children.
A variety of specific and nonspecific oral lesions can occur (Table 3). Differences in the percentage of patients with IBD described with oral lesions may relate to specific versus nonspecific oral findings reported. Aphthous ulcers are considered by many to be nonspecific, as they can be seen in up to 20% of the general population; however, aphthae are usually more extensive and persistent when associated with IBD.15 The descriptive term "orofacial granulomatosis" has been used for any granulomatous process of unknown etiology involving the oral cavity,16 which includes disorders previously described as granulomatous cheilitis and partial Melkersson-Rosenthal syndrome. Orofacial granulomatosis is a common manifestation in children with IBD and is typified by recurrent or persistent swelling of the lips, cheeks, gingiva, or oral mucosa with characteristic noncaseating granulomas on histologic examination. Many patients with orofacial granulomatosis do eventually develop gastrointestinal disease consistent with Crohn's disease.20,21 "Cobblestoning" refers to nodular granulomatous swellings that result in a cobblestone appearance of the oral mucosa, particularly on the labial and buccal mucosa. Along with mucosal tags, cobblestoning is highly suggestive of Crohn's disease. Pyostomatitis vegetans, on the other hand, is more characteristic of ulcerative colitis. It is characterized by multiple pustules, erosions, and ulcers on a diffuse erythematous background with vegetations or folding of the gingival and buccal mucosa. Deep, linear ulcers surmounted by hyperplastic folds occur in the gingival sulci and are also specific for IBD.
Genital findings associated with IBD are also more common in Crohn's disease and in children.1 Genital involvement includes vulvar swelling, skin tags, pustules, abscesses, fistulas, fissures, ulcerations, and vaginal discharge.22 Penile and scrotal lesions are less common and include subcoronal ulcers as well as penile and scrotal edema.23 Twenty-five percent of genital Crohn's disease presents before gastrointestinal complaints.1
Although there are few cases reported in the pediatric literature, mucocutaneous lesions presenting as the initial sign of IBD is relatively common and can be an important clue in making the diagnosis of IBD before the development of gastrointestinal symptoms. We have identified 9 pediatric patients with asymptomatic IBD presenting with mucocutaneous lesions. The majority of these patients had oral and/or perianal lesions. Because oral disease, in general, is uncommon in children, we believe that IBD is a common etiology for persistent oral lesions in the pediatric population. Children and adolescents with unexplained oral mucous membrane lesions such as lip/mucosal swelling, gingival hyperplasia, cobblestoning of the oral mucosa, or deep linear ulcerations should have a good history taken regarding gastrointestinal symptoms, fever, and weight loss as well as an examination of the rectal and genital mucosa to seek other mucocutaneous clues of IBD that may not be mentioned to the physician. We would also recommend additional work-up including complete blood count, iron levels, ESR, albumin, occult blood in the stool, and serial endoscopies with biopsies to aid in the diagnosis if suspicions are high.
FOOTNOTES
Accepted Mar 31, 2005.
No conflict of interest declared.
REFERENCES
Ploysangam T, Heubi JE, Eisen D, Balistreri WF, Lucky AW. Cutaneous Crohn's disease in children. J Am Acad Dermatol. 1997:36 :697 –704
McCallum DI, Kinmont PD. Dermatological manifestations of Crohn's disease. Br J Dermatol. 1968;80 :1 –8
Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55 :401 –412
Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease. An analysis of 79 cases. J Clin Gastroenterol. 1991;13 :29 –37
Gregory B, Ho VC. Cutaneous manifestations of gastrointestinal disorders. Part II. J Am Acad Dermatol. 1992:26 (3 pt 2):371–383
Burgdorf WH. Cutaneous manifestations of Crohn's disease. J Am Acad Dermatol. 1981;5 :689 –695
Apgar JT. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Semin Dermatol. 1991;10 :138 –147
Powell FC, Perry HO. Pyoderma gangrenosum in childhood. Arch Dermatol. 1984;120 :757 –761
Paller AS, Sahn EE, Garen PD, Dobson RL, Chadwick EG. Pyoderma gangrenosum in pediatric acquired immunodeficiency syndrome. J Pediatr. 1990:117 :63 –66
Gilman AL, Cohen BA, Urback AH, Blatt J. Pyoderma gangrenosum as a manifestation of leukemia in childhood. Pediatrics. 1988;81 :846 –848
Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol. 1985;80 :615 –620
Baker WN, Milton-Thompson GJ. The anal lesion as the sole presenting symptom of intestinal Crohn's disease. Gut. 1971;12 :865
Lebwohl M, Lebwohl O. Cutaneous manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 1998;4 :142 –148
Basu MK, Asquith P. Oral manifestations of inflammatory bowel disease. Clin Gastroenterol. 1980;9 :307 –321
Berstein ML, McDonald JS. Oral lesions in Crohn's disease: report of two cases and update of the literature. Oral Surg Oral Med Oral Pathol. 1978;46 :234 –245
Wiesenfeld D, Ferguson MM, Mitchell DN, et al. Oro-facial granulomatosis—a clinical and pathological analysis. Q J Med. 1985;54 :101 –113
Williams AJ, Wray D, Ferguson A. The clinical entity of orofacial Crohn's disease. Q J Med. 1991;79 :451 –458
Barnard KM, Walker-Smith JA. The prevalence of oral manifestations of inflammatory bowel disease in a paediatric population . J Dent Res. 1994;73 :A388
Pittock S, Drumm B, Fleming P, et al. The oral cavity in Crohn's disease. J Pediatr. 2001;138 :767 –771
Scully C, Cochran KM, Russell RI, et al. Crohn's disease of the mouth: an indicator of intestinal involvement. Gut. 1982;23 :198 –201
Bogenrieder T, Rogler G, Vogt T, Landthaler M, Stolz W. Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent. Dermatology. 2003;206 :273 –278
van de Scheur MR, van der Waal RI, van der Waal I, Stoof TJ, van Deventer SJ. Ano-genital granulomatosis: the counterpart of oro-facial granulomatosis. J Eur Acad Dermatol Venereol. 2003;17 :184 –189
Poon KS, Gilks CB, Masterson JS. Metastatic Crohn's disease involving the genitalia. J Urol. 2002;167 :2541 –2542(Sheila S. Galbraith, MD, )
Department of Gastroenterology and Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin
Department of Dermatology and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
ABSTRACT
Although inflammatory bowel disease (IBD) typically presents with gastrointestinal complaints, mucocutaneous lesions are commonly associated and can precede gastrointestinal symptoms, thereby alerting the clinician to the diagnosis of IBD before the onset of gastrointestinal symptoms. Nine children are reported who had no gastrointestinal symptoms suggestive of IBD but presented with mucocutaneous findings of IBD and were subsequently diagnosed with Crohn's disease or ulcerative colitis based on characteristic features on gastrointestinal endoscopy and/or biopsies. The majority of the patients had oral and perianal lesions. We believe that IBD is a common etiology for persistent oral lesions in the pediatric population. In addition to a good history, children with unexplained oral mucous membrane lesions should have an examination of the rectal and genital mucosa as well as tests for complete blood count, iron levels, sedimentation rate, albumin, and occult blood in the stool with endoscopy and biopsies to rule out IBD if indicated.
Key Words: Crohn's disease cutaneous inflammatory bowel disease oral pediatrics
Abbreviations: IBD, inflammatory bowel disease 6-MP, 6-mercaptopurine ESR, erythrocyte sedimentation rate
Inflammatory bowel disease (IBD) is a group of gastrointestinal disorders characterized by relapsing and remitting signs and symptoms. Intestinal manifestations such as abdominal pain, diarrhea, fever, weight loss, and extraintestinal manifestations including mucocutaneous lesions, iritis, and arthritis may be associated with IBD. Mucocutaneous lesions are relatively common during the course of IBD. Less commonly, however, they can be a presenting finding, thereby alerting the clinician to the diagnosis of IBD before the onset of gastrointestinal symptoms. We describe 9 children from 2 medical institutions in whom mucocutaneous lesions preceded abdominal manifestations and led to an early diagnosis of IBD.
REPRESENTATIVE CASES
Patient 1
A 6-year-old white boy presented with a 5-month history of intermittent upper-lip swelling associated with eczematous skin changes and gingival edema (Fig 1). Over the subsequent 3 years, he developed worsening of the upper-lip swelling as well as angular cheilitis and lower-lip involvement (Fig 2). He denied any systemic symptoms including facial paralysis, abdominal pain, and diarrhea. A biopsy specimen from the oral mucosa showed a hyperplastic mucosa with spongiosis and a dense lymphocytic infiltrate with small granulomas in the submucosa. Patch tests, complete blood count, tuberculosis skin tests, chest radiograph, and pulmonary function tests were within normal limits.
A repeat biopsy was planned because of lack of improvement with several therapies including topical steroids, antihistamines, amoxicillin-clavulanate, and minocycline for presumed Melkersson-Rosenthal syndrome. On returning to the clinic for biopsy, his mother mentioned a perianal pustule that had been present for some time. Given this new information, the oral biopsy was not performed; he instead was referred to a gastroenterologist. The patient was found to have microcytic anemia (hemoglobin: 11.1 g/dL; mean corpuscular volume: 75 fL) and hypoalbuminemia (3.3 g/dL) at that time. Esophagogastroduodenoscopy was unremarkable; however, patchy erythema, erosions, and pseudopolyps were seen during colonoscopy. Biopsies from the colon showed gastritis, terminal ileum granulomas, and granulomatous colitis, confirming the diagnosis of Crohn's disease.
The perianal lesion proved to be a fistula, and 6-mercaptopurine (6-MP) was started. Metronidazole was added intermittently to treat the fistula further. There was mild improvement of the granulomatous cheilitis; however, the fistula remained patent. Infliximab was started, with complete resolution of the oral lesions, closure of the fistula, and normalization of laboratory abnormalities after 3 infusions. He is in clinical and biochemical remission without intestinal or extraintestinal manifestations while maintained on scheduled 8- to 10-week-interval infliximab therapy.
Patient 2
An 8-year-old white boy had a 2-year history of recurrent oral ulcerations with hyperplastic ridges in the inferior gingival sulcus bilaterally (Fig 3). He denied any gastrointestinal symptoms. A previous oral biopsy was reviewed and showed a small granuloma in the submucosa. He also had a history of perianal skin tags and fissures. Gastrointestinal evaluation revealed esophagitis, gastritis, and multiple aphthous ulcers in the sigmoid colon. Biopsy specimens showed esophagitis with granulomas and granulomatous colitis consistent with Crohn's disease. Work-up subsequently revealed hypoalbuminemia (3.2 g/dL) and an elevated erythrocyte sedimentation rate (ESR) (32 mm/hour). Monotherapy with 6-MP resulted in resolution of his oral ulcers.
Patient 3
A 12-year-old obese white boy (body mass index: 97th percentile) presented with a 6-month history of an erythematous plaque on his right lower extremity that more recently had become warm to the touch, tender, and ulcerated with indurated violaceous borders (Fig 4). The patient denied any trauma to the area. Two biopsies performed elsewhere were consistent with folliculitis, and the patient had been treated with Augmentin and topical antibiotics with no improvement. Repeat biopsy showed suppurative folliculitis which, along with the typical clinical presentation, was consistent with pyoderma gangrenosum. Fungal culture and acid-fast bacillus stains were negative. His ESR was slightly elevated (14 mm/hour). The patient denied any gastrointestinal complaints, but upper and lower endoscopy showed multiple ulcerations in the gastric antrum and ileum. Biopsy specimens showed gastritis, ileitis, and crypt destruction with giant-cell reaction in the colon consistent with Crohn's disease. He initially received intralesional corticosteroids for the pyoderma gangrenosum; however, after the diagnosis of Crohn's disease was made, infliximab and methotrexate were initiated, which led to almost complete resolution of the pyoderma gangrenosum.
RESULTS
In our series of children with silent IBD, mucocutaneous lesions appeared before gastrointestinal signs as the manifestation of Crohn's disease (8 of 9) or ulcerative colitis (1 of 9). (Table 1 provides a summary of these cases.) Of the 9 patients, 8 were male, and the mean age was 8 years. Although patients with IBD tend not to be overweight, 2 of our patients were obese (patients 3 and 8). Six children presented with oral manifestations, 1 had genital lesions, and 2 had pyoderma gangrenosum. All patients were asked about gastrointestinal symptoms, fever, weight loss, and joint pain at presentation and denied any such symptoms. The majority of our patients (7 of 9) had perianal lesions at presentation; however, several of the perianal lesions were not discovered on initial evaluation but only became apparent during subsequent examinations. The time to diagnosis of IBD after development of the mucocutaneous findings ranged from 1 month to 42 months. In general, patients with oral and perianal lesions experienced a longer time until diagnosis compared with patients with lesions that presented elsewhere. One patient (patient 8) was diagnosed with Crohn's disease on repeat endoscopy after the initial endoscopy that was performed 1.5 years prior was normal. In all patients followed after instituting therapy, the mucocutaneous lesions responded to therapy for their IBD.
DISCUSSION
Although IBD typically presents with gastrointestinal complaints, mucocutaneous lesions have been reported to occur in 15% to 44% of cases and, when present, can precede gastrointestinal symptoms.1,2,3,4 Gregory and Ho5 reviewed the mucocutaneous lesions of IBD and divided them into specific, reactive, and miscellaneous categories (Table 2).
Although uncommon in children, pyoderma gangrenosum is a common mucocutaneous feature of IBD. Typically, the early papulopustules or hemorrhagic bullae rapidly enlarge, become necrotic, and ulcerate. The ulcerations have a characteristic violaceous, undermined border (Fig 4). Lesions can occur on any part of the body but are most frequently located on the lower extremities. Pyoderma gangrenosum is characterized by pathergy (predilection for lesions in areas of trauma); thus, aggressive debridement must be avoided. Twenty percent of adult patients with pyoderma gangrenosum will have associated IBD.6 It is associated more commonly with ulcerative colitis than Crohn's disease, occurring in 5% to 12% and 1% to 2% of patients, respectively.3,5,7 Pyoderma gangrenosum is uncommon in children, with 4% of cases reported in children <15 years old.8 Although IBD is the most common underlying cause of pyoderma gangrenosum in children, pyoderma gangrenosum in children can be associated with several other systemic disorders including immunodeficiencies (primary and HIV related), leukemia, hepatitis, and arthritis.9,10 The occurrence of pyoderma gangrenosum preceding gastrointestinal symptoms in IBD has only been described in a few patients.6,8,11
Perianal lesions including skin tags, fistulas, fissures, and abscesses are characteristic of Crohn's disease and occur during the course of IBD in 60% to 82% of patients; however, 25% to 30% of patients show perianal lesions before gastrointestinal complaints.12,13 The majority of our patients with Crohn's disease (6 of 8), as well as our 1 patient with ulcerative colitis, were noted to have perianal lesions before gastrointestinal symptoms. It is interesting to note that the 2 patients with Crohn's disease who did not have perianal lesions had pyoderma gangrenosum as their initial finding. Of the patients with perianal lesions, in only 2 (patients 8 and 9) was the perianal lesion the presenting complaint. This suggests that perianal lesions may often be present before gastrointestinal complaints but are less often brought to the attention of the physician, especially in adolescent boys.
Although not as well documented, oral lesions associated with IBD are relatively common, occurring in 6% to 20% of patients.14 When present, they are the presenting sign/symptom in approximately one half of cases.1,4,15–1617 In addition, more recent reviews have found an increased prevalence of various oral lesions in IBD, particularly in children. Barnard and Walker-Smith found that 80% of pediatric patients with Crohn's disease and 41% of children with ulcerative colitis had oral lesions in their series of patients.18 In reviews by Pittock et al19 and Plauth et al,4 48% and 66% of patients with Crohn's disease, respectively, were found to have oral manifestations, with an increased prevalence in children.
A variety of specific and nonspecific oral lesions can occur (Table 3). Differences in the percentage of patients with IBD described with oral lesions may relate to specific versus nonspecific oral findings reported. Aphthous ulcers are considered by many to be nonspecific, as they can be seen in up to 20% of the general population; however, aphthae are usually more extensive and persistent when associated with IBD.15 The descriptive term "orofacial granulomatosis" has been used for any granulomatous process of unknown etiology involving the oral cavity,16 which includes disorders previously described as granulomatous cheilitis and partial Melkersson-Rosenthal syndrome. Orofacial granulomatosis is a common manifestation in children with IBD and is typified by recurrent or persistent swelling of the lips, cheeks, gingiva, or oral mucosa with characteristic noncaseating granulomas on histologic examination. Many patients with orofacial granulomatosis do eventually develop gastrointestinal disease consistent with Crohn's disease.20,21 "Cobblestoning" refers to nodular granulomatous swellings that result in a cobblestone appearance of the oral mucosa, particularly on the labial and buccal mucosa. Along with mucosal tags, cobblestoning is highly suggestive of Crohn's disease. Pyostomatitis vegetans, on the other hand, is more characteristic of ulcerative colitis. It is characterized by multiple pustules, erosions, and ulcers on a diffuse erythematous background with vegetations or folding of the gingival and buccal mucosa. Deep, linear ulcers surmounted by hyperplastic folds occur in the gingival sulci and are also specific for IBD.
Genital findings associated with IBD are also more common in Crohn's disease and in children.1 Genital involvement includes vulvar swelling, skin tags, pustules, abscesses, fistulas, fissures, ulcerations, and vaginal discharge.22 Penile and scrotal lesions are less common and include subcoronal ulcers as well as penile and scrotal edema.23 Twenty-five percent of genital Crohn's disease presents before gastrointestinal complaints.1
Although there are few cases reported in the pediatric literature, mucocutaneous lesions presenting as the initial sign of IBD is relatively common and can be an important clue in making the diagnosis of IBD before the development of gastrointestinal symptoms. We have identified 9 pediatric patients with asymptomatic IBD presenting with mucocutaneous lesions. The majority of these patients had oral and/or perianal lesions. Because oral disease, in general, is uncommon in children, we believe that IBD is a common etiology for persistent oral lesions in the pediatric population. Children and adolescents with unexplained oral mucous membrane lesions such as lip/mucosal swelling, gingival hyperplasia, cobblestoning of the oral mucosa, or deep linear ulcerations should have a good history taken regarding gastrointestinal symptoms, fever, and weight loss as well as an examination of the rectal and genital mucosa to seek other mucocutaneous clues of IBD that may not be mentioned to the physician. We would also recommend additional work-up including complete blood count, iron levels, ESR, albumin, occult blood in the stool, and serial endoscopies with biopsies to aid in the diagnosis if suspicions are high.
FOOTNOTES
Accepted Mar 31, 2005.
No conflict of interest declared.
REFERENCES
Ploysangam T, Heubi JE, Eisen D, Balistreri WF, Lucky AW. Cutaneous Crohn's disease in children. J Am Acad Dermatol. 1997:36 :697 –704
McCallum DI, Kinmont PD. Dermatological manifestations of Crohn's disease. Br J Dermatol. 1968;80 :1 –8
Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55 :401 –412
Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease. An analysis of 79 cases. J Clin Gastroenterol. 1991;13 :29 –37
Gregory B, Ho VC. Cutaneous manifestations of gastrointestinal disorders. Part II. J Am Acad Dermatol. 1992:26 (3 pt 2):371–383
Burgdorf WH. Cutaneous manifestations of Crohn's disease. J Am Acad Dermatol. 1981;5 :689 –695
Apgar JT. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Semin Dermatol. 1991;10 :138 –147
Powell FC, Perry HO. Pyoderma gangrenosum in childhood. Arch Dermatol. 1984;120 :757 –761
Paller AS, Sahn EE, Garen PD, Dobson RL, Chadwick EG. Pyoderma gangrenosum in pediatric acquired immunodeficiency syndrome. J Pediatr. 1990:117 :63 –66
Gilman AL, Cohen BA, Urback AH, Blatt J. Pyoderma gangrenosum as a manifestation of leukemia in childhood. Pediatrics. 1988;81 :846 –848
Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol. 1985;80 :615 –620
Baker WN, Milton-Thompson GJ. The anal lesion as the sole presenting symptom of intestinal Crohn's disease. Gut. 1971;12 :865
Lebwohl M, Lebwohl O. Cutaneous manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 1998;4 :142 –148
Basu MK, Asquith P. Oral manifestations of inflammatory bowel disease. Clin Gastroenterol. 1980;9 :307 –321
Berstein ML, McDonald JS. Oral lesions in Crohn's disease: report of two cases and update of the literature. Oral Surg Oral Med Oral Pathol. 1978;46 :234 –245
Wiesenfeld D, Ferguson MM, Mitchell DN, et al. Oro-facial granulomatosis—a clinical and pathological analysis. Q J Med. 1985;54 :101 –113
Williams AJ, Wray D, Ferguson A. The clinical entity of orofacial Crohn's disease. Q J Med. 1991;79 :451 –458
Barnard KM, Walker-Smith JA. The prevalence of oral manifestations of inflammatory bowel disease in a paediatric population . J Dent Res. 1994;73 :A388
Pittock S, Drumm B, Fleming P, et al. The oral cavity in Crohn's disease. J Pediatr. 2001;138 :767 –771
Scully C, Cochran KM, Russell RI, et al. Crohn's disease of the mouth: an indicator of intestinal involvement. Gut. 1982;23 :198 –201
Bogenrieder T, Rogler G, Vogt T, Landthaler M, Stolz W. Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent. Dermatology. 2003;206 :273 –278
van de Scheur MR, van der Waal RI, van der Waal I, Stoof TJ, van Deventer SJ. Ano-genital granulomatosis: the counterpart of oro-facial granulomatosis. J Eur Acad Dermatol Venereol. 2003;17 :184 –189
Poon KS, Gilks CB, Masterson JS. Metastatic Crohn's disease involving the genitalia. J Urol. 2002;167 :2541 –2542(Sheila S. Galbraith, MD, )